泼尼松联合舒血宁注射液治疗肺间质纤维化120例

目的 探讨泼尼松联合舒血宁注射液治疗肺间质纤维化的临床疗效.方法 将120例肺间质纤维化患者随机分两组各60例,对照组采用泼尼松治疗,治疗组在对照组治疗基础上加用舒血宁注射液治疗,比较两组患者治疗前后的症状改善、肺活量(VC)、动脉氧分压(PO_2)、二氧化碳分压(PCO_2)及影像学变化.结果 治疗组总有效率为81.67%,对照组总有效率为66.67%,治疗组优于对照组(t=3.21,P<0.05).两组的VC均提高(P<0.05),治疗组优于对照组(P<0.05);两组的PO_2都提高,治疗前后均有统计学差异(P<0.05),治疗组提高幅度大于对照组(P<0.05):两组的PCO_2都升高,治疗前后均有统计学差异(P<0.05),组间比较无显著性差异(P>0.05).治疗组27例(45.00%)、对照组19例(31.67%)有影像学改善.治疗组优于对照组(P<0.05).结论 泼尼松联合舒血宁注射液治疗肺间质纤维化效果优于单纯泼尼松治疗.

Research on treatment of 120 cases of pulmonary Interstitial fibrosis with prednisone anti Shuxuening Injection

Objective To study the clinical effect ofprednisone combined with Shuxuening injection on pulmonary interstitial fibrosis. Methods 120 cases were randomly recruited into a treatment group and a control group. The control group was treated with prednisone, and the treatment group was additionally given Shuxuening injection on the basis of the control group. The changes of vital capacity (VC), PO_2, PCO_2 and imaging were observed. Results The total effective rate was 81.67% and 66.67% in the treatment group and the control group Respectively, showing significant difference (P<0.05). VC and PO_2 were raised in both groups after the treatment (P<0.05), while the treatment group showed better results than the control group (P<0.05). PCO2 were also raised in both groups after the treatment (P<0.05), while there was no significant diference between the two groups (P > 0.05). There were 27 cases (45.00%) and 19 cases (31.67%) showed improvement in imaging in the treatment group and the control group respectively, manifesting a significant difference (P<0.05) . Conclusion Treatment of prednisone with Shuxuening injection is better than prednisone on pulmonary interstitial fibrosis. This method is worthy of clinic promotion.